ATI RN
ATI RN Pharmacology 2023 II Questions
Extract:
Question 1 of 5
A nurse is assessing the vital signs of a client who is taking amiodarone. The nurse should anticipate which of the following findings as an adverse effect of the medication?
Correct Answer: C
Rationale: The correct answer is C: Bradycardia. Amiodarone is an antiarrhythmic medication that can cause bradycardia as an adverse effect due to its impact on the electrical conduction system of the heart. This can lead to a slow heart rate, which can be concerning for the client's overall cardiovascular function. Bradypnea (
A) refers to slow breathing rate, which is not a typical adverse effect of amiodarone. Fever (
B) is not a common adverse effect of amiodarone and should prompt further investigation for other causes. Hypertension (
D) is not a typical adverse effect of amiodarone; in fact, it is more likely to cause hypotension.
Question 2 of 5
A nurse is administering 4 mg of hydromorphone to a client by mouth every 4 hr. The medication is provided as hydromorphone 8 mg per tablet. Which of the following actions is appropriate for the nurse to take?
Correct Answer: B
Rationale: The correct answer is B: Dispose of the remaining medication while another nurse observes. This is appropriate to ensure proper disposal of the unused portion of the medication to prevent diversion or misuse. By disposing of the remaining medication with another nurse observing, it ensures accountability and adherence to medication safety protocols.
Choice A is incorrect because returning the medication to the facility's pharmacy can lead to confusion and potentially unsafe practices.
Choice C is incorrect as storing the remaining half of the pill in the automated medication dispensing system can lead to errors in medication administration.
Choice D is incorrect as placing the remaining half of the pill in the unit-dose package can also result in medication errors. It is essential to follow proper disposal procedures to maintain patient safety and prevent medication errors.
Question 3 of 5
A nurse is reviewing the laboratory data of a client who is receiving filgrastim. Which of the following laboratory values should the nurse monitor to evaluate the effectiveness of the treatment?
Correct Answer: B
Rationale: The correct answer is B: WBC count. Filgrastim is a medication that stimulates the production of white blood cells (WBCs). Monitoring the WBC count is essential to evaluate the effectiveness of the treatment as an increase in WBC count indicates the medication is working to boost the immune system.
Incorrect options:
A: INR (International Normalized Ratio) is used to monitor the effectiveness of anticoagulant therapy, not filgrastim.
C: Potassium level monitoring is important for clients taking certain medications that can affect potassium levels, but not specifically for evaluating the effectiveness of filgrastim.
D: BUN (Blood Urea Nitrogen) is a measure of kidney function and hydration status, not related to evaluating the effectiveness of filgrastim.
Question 4 of 5
A nurse is monitoring a client's peripheral IV infusion of a vesicant medication and observes swelling and coolness of the skin at the insertion site. After stopping the infusion, which of the following actions should the nurse take next?
Correct Answer: D
Rationale: The correct answer is D: Remove the IV catheter. Swelling and coolness at the insertion site indicate extravasation, which is the leakage of vesicant medication into the surrounding tissue, causing potential tissue damage. Removing the IV catheter immediately helps prevent further infiltration and tissue injury. Notifying the provider (
A) can be done after removing the catheter. Applying warm compress (
B) is incorrect as it can increase the absorption of the vesicant and worsen tissue damage. Aspirating fluid (
C) may not be effective in removing the medication from the tissue.
Question 5 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Administer the medication into the anterolateral or posterolateral abdominal area. Enoxaparin is a low molecular weight heparin that should be injected subcutaneously into the fatty tissue in the abdomen. This area has a good blood supply, allowing for better absorption of the medication. The nurse should choose an area away from the umbilicus and any scar tissue to prevent discomfort and ensure proper absorption. Massaging the injection site after administering the medication (
Choice
A) is not recommended as it can cause bruising and discomfort. Holding the skin taut at the injection site (
Choice
C) is unnecessary and may increase the risk of injecting the medication too deeply. Expelling the air bubble from the syringe (
Choice
D) is not necessary for subcutaneous injections and may lead to medication wastage.